Gattei, V, et al., “CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin,” Blood 89(6):2408-2059, 1997. |
GenBank Accession No. AI091180, 1997. |
GenBank EST Database Accession No. A1830832, (gi:5451425) wj52c06.x1 NCI_CGAP_Lu 19 Homo sapiens cDNA clone (see USPTO Search Report US-09-597-2.rst, result 1). |
GenBank Accession No. U56940 (gi:1708675), “Human MHC class I chain-related gene A (MICA 001 allel), partial cds.”. |
GenBank Accession No. U65416 (gi:1815636), “Human MHC class I molecular (MICB) gene, complete cds.”. |
GenBank Accession No. R25716, 1995. |
Girardi, M, et al., “Regulation of cutaneous malignancy by γδ T cells,” Science 294:605-609, 2001. |
Gura, T, “Systems for identifying drugs are often faulty,” Science 278:1041-1042, 1997. |
Harris, PC et al., “Polycystic kidney disease 1: identification and analysis of the primary defect,” J Am Soc Nephrol 6:1125-1133, 1995. |
Janeway et al., Immunobiology, Current Biology Ltd., London (1994) pp 9:20-9:24. |
Lazar et al., “Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities,” Molecular and Cellular Biology 8:1247-1252, 1998. |
Luo et al., “Rat hepatic natural killer cell (pit cells) express mRNA and protein similar to in Vitro Interleukin-2 activated spleen natural killer cells,” Cell. Immunol. 210:41-48, 2001. |
Myers, D and Uckun, F, “An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia,” Leukemia and Lymphoma 18:119-122, Harwood Academic Publishers GmbH, Printed in Singapore, 1995. |
Scott et al., “The pendered syndrome gene encodes a chloride-iodide transport protein,” Nature Genetics 21:440-443, 1999. |
Steinle, A, et al., Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family, Immunogenetics 53:279-287, 2001. |
Sun, T, et al., “Histiocyte-rich B-cell lymphoma,” Human Pathology 28(11):1321-1324, 1997. |
Whiteside, T and Herberman, R, “The role of natural killer cells in immune surveillance of cancer,” Current Opinion in Immunology 7:704-710, 1995. |
Yamabe et al., “Induction of the 2B9 antigen/dipeptiyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 and IL-15,” Immunology 91:151-158, 1997. |